Gucalp, Ayca

Publications

Sort by

Co-Author Network

selected publications

"A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan Kettering. Journal of oncology practice. 2019 Academic Article GET IT
Male breast cancer: a disease distinct from female breast cancer. Breast cancer research and treatment. 2018 Review GET IT
Times cited: 135
The microbial flora of taxane therapy-associated nail disease in cancer patients. Journal of the American Academy of Dermatology. 2018 Letter GET IT
Times cited: 4
A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease. Cancer prevention research (Philadelphia, Pa.). 2018 Academic Article GET IT
Times cited: 13
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 292
Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link. International journal of obesity (2005). 2017 Academic Article GET IT
Times cited: 45
The Androgen Receptor: Is It a Promising Target?. Annals of surgical oncology. 2017 Review GET IT
Times cited: 20
Periprostatic adipose inflammation is associated with high-grade prostate cancer. Prostate cancer and prostatic diseases. 2017 Academic Article GET IT
Times cited: 54
Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers. The Journal of clinical endocrinology and metabolism. 2017 Academic Article GET IT
Times cited: 65
Androgen receptor-positive, triple-negative breast cancer. Cancer. 2017 Academic Article GET IT
Times cited: 10
A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 40
Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index. Cancer prevention research (Philadelphia, Pa.). 2017 Academic Article GET IT
Times cited: 108
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Review GET IT
Times cited: 453
Targeting the androgen receptor in triple-negative breast cancer. Current problems in cancer. 2016 Review GET IT
Times cited: 65
Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 136
Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression. Seminars in oncology. 2015 Review GET IT
Times cited: 29
Menopause is a determinant of breast adipose inflammation. Cancer prevention research (Philadelphia, Pa.). 2015 Academic Article GET IT
Times cited: 79
American Society of Clinical Oncology position statement on obesity and cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 343
Palbociclib: an evidence-based review of its potential in the treatment of breast cancer. Breast cancer (Dove Medical Press). 2014 Review GET IT
Times cited: 91
Advances in managing breast cancer: a clinical update. F1000prime reports. 2014 Review GET IT
Times cited: 2260
Omega-3 fatty acids for the prevention of breast cancer: an update and state of the science. Current breast cancer reports. 2013 Academic Article GET IT
Times cited: 21
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013 Academic Article GET IT
Times cited: 520
The role of the androgen receptor in triple-negative breast cancer. Women's health (London, England). 2013 Review GET IT
Times cited: 36
Skin necrosis induced by generic enoxaparin. American journal of hematology. 2013 Letter GET IT
Triple-negative breast cancer: adjuvant therapeutic options. Chemotherapy research and practice. 2011 Academic Article GET IT
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer. Clinical breast cancer. 2011 Academic Article GET IT
Times cited: 109
Spectrum of HIV lymphoma 2009. Current opinion in hematology. 2010 Review GET IT
Times cited: 18
Triple-negative breast cancer: role of the androgen receptor. Cancer journal (Sudbury, Mass.). 2010 Review GET IT
Times cited: 113

more ...

less ...

Background

education and training

M.D., Albert Einstein College of Medicine of Yeshiva University 2005
B.A., University of Pennsylvania 2001

Contact

full name

Ayca Gucalp

VIVO Weill Cornell Medical College

Ayca Gucalp Assistant Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name